Surgery Partners, Inc. declines Bain Capital's $25.75/share offer, citing growth potential. Click for my updated look at SGRY ...

Recent news in the health sector includes Surgery Partners' rejection of Bain Capital's take-private offer, Purdue Pharma's ...

Two major deals on June 17 are poised to reshape the competitive landscape of ASCs: Ascension’s definitive agreement to acquire AmSurg, and Surgery Partners’ rejection of a buyout bid from Bain ...

A recent Bloomberg report said the deal is worth nearly $4 billion. Not happening, however, is Bain Capital buying all of ...